The estimated Net Worth of David W. Dunn is at least $4.54 Milion dollars as of 12 March 2012. David Dunn owns over 630 units of Cencora stock worth over $4,528,574 and over the last 14 years David sold COR stock worth over $14,055.
David has made over 2 trades of the Cencora stock since 2010, according to the Form 4 filled with the SEC. Most recently David sold 630 units of COR stock worth $14,055 on 12 March 2012.
The largest trade David's ever made was buying 2,250 units of Cencora stock on 7 December 2010 worth over $30,488. On average, David trades about 480 units every 77 days since 2010. As of 12 March 2012 David still owns at least 19,171 units of Cencora stock.
You can see the complete history of David Dunn stock trades at the bottom of the page.
David's mailing address filed with the SEC is 1050 17TH STREET, SUITE 800, , DENVER, CO, 80265.
Over the last 14 years, insiders at Cencora have traded over $67,682,023 worth of Cencora stock and bought 34,206 units worth $1,080,918 . The most active insiders traders include Realty Iii, Gp, L.L.C.Carly..., Iv Aiv Gp, L.L.C.Crp Iv Aiv... oraz Group Management L.L.C.Carl.... On average, Cencora executives and independent directors trade stock every 13 days with the average trade being worth of $18,365,869. The most recent stock trade was executed by Brian Warren on 5 November 2021, trading 850 units of COR stock currently worth $130,577.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Cencora executives and other stock owners filed with the SEC include: